May 2, 2026

Featuring perspectives from Dr Stacey A Cohen, Dr Christopher Lieu and Dr Jenny Seligmann, moderated by Dr Lieu, including the following topics:

• Role of circulating tumor DNA (ctDNA) testing in the escalation of treatment for Stage II and deescalation for Stage III colon cancer (0:00)
• Impact of timing on the clinical...

Apr 25, 2026

Featuring perspectives from Dr Jaffer A Ajani, Dr Samuel J Klempner, Dr Rutika Mehta and Dr John Strickler, moderated by Dr Klempner, including the following topics:

• Role of PD-L1 status, tumor histology and pulmonary disease in selection of immune checkpoint inhibition as up-front therapy (0:00)
• Impact of metastatic...

Apr 13, 2026

Featuring perspectives from Dr Stacey A Cohen, Dr Christopher Lieu and Dr Jenny Seligmann, moderated by Dr Lieu, including the following topics:

• Adjuvant treatment planning for Stage II or III microsatellite instability-high colon cancer (0:00)
• Roles of circulating tumor DNA (ctDNA), POLE mutations and advanced age in...

Apr 8, 2026

Featuring perspectives from Dr Haley Ellis, Prof Eric Van Cutsem and Dr Zev Wainberg, moderated by Dr Lionel A Kankeu Fonkoua, including the following topics:

• Gastroesophageal cancer (0:00)
• Recurrent colorectal cancer (5:43)
• Colorectal cancer with brain metastases (9:59)

CME information and select...

Apr 3, 2026

Featuring perspectives from Dr Jaffer A Ajani, Dr Samuel J Klempner, Dr Rutika Mehta and Dr John Strickler, moderated by Dr Klempner, including the following topics:

• Older patient with metastatic claudin 18.2-positive gastroesophageal (GE) cancer (0:00)
• Management of nausea and vomiting with zolbetuximab for GE cancer...